SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of The Toronto-Dominion Bank

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In TD To Contact Him Directly To Discuss Their Options

If you suffered losses exceeding $100,000 in TD between February 29, 2024 to October 9, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - November 7, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Toronto-Dominion Bank ("TD" or the "Company") (NYSE: TD) and reminds investors of the December 23, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that defendants provided investors with material information concerning the scope of the issues surrounding TD's anti-money laundering ("AML") program employed to comply with the United States' Bank Secrecy Act ('BSA"), the ability for defendants to "fix" those issues, and the punitive and remedial compliance measures likely to be imposed upon TD through the resolution of these investigations. Defendants' statements included, among other things, confidence in the Company's optimistic claims of updating and fixing the existing AML program, alleging a full understanding of the scope of the issues the program was facing, and setting aside specific provisional estimates as to the monetary impact of the punitive and compliance measures believed to be imposed.

Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of TD's AML program; pertinently, TD concealed or otherwise minimized the significance of the failures of the Company's AML program and made no indication that the imposition of an asset cap or other punitive or compliance measures would be imposed that would undermine TD's continued growth for the foreseeable future. Such statements absent these material facts caused shareholders to purchase TD's securities at artificially inflated prices.